The tumor suppressor protein BRCA2 is a key component of the homologous recombination pathway of DNA repair, acting as the loader of RAD51 recombinase at sites of double-strand breaks. Here we show that BRCA2 associates with telomeres during the S and G2 phases of the cell cycle and facilitates the loading of RAD51 onto telomeres. Conditional deletion of Brca2 and inhibition of Rad51 in mouse embryonic fibroblasts (MEFs), but not inactivation of Brca1, led to shortening of telomeres and accumulation of fragmented telomeric signals-a hallmark of telomere fragility that is associated with replication defects. These findings suggest that BRCA2-mediated homologous recombination reactions contribute to the maintenance of telomere length by facilitating telomere replication and imply that BRCA2 has an essential role in maintaining telomere integrity during unchallenged cell proliferation. Mouse mammary tumors that lacked Brca2 accumulated telomere dysfunction-induced foci. Human breast tumors in which BRCA2 was mutated had shorter telomeres than those in which BRCA1 was mutated, suggesting that the genomic instability in BRCA2-deficient tumors was due in part to telomere dysfunction.
Germline mutations in one allele of BRCA2 are associated with a high susceptibility to breast and ovarian cancers. Female carriers of one mutant BRCA2 allele have a cumulative probability throughout their lifetime of 80% and 20% for developing breast and ovarian tumors, respectively 1 . At the cellular level, BRCA2 interacts directly with the RAD51 recombinase and regulates recombination-mediated repair of double-strand breaks (DSBs), and this is thought to account for the high levels of spontaneous chromosomal aberrations seen in BRCA2defective cells (reviewed in refs. [2] [3] [4] .
Homologous recombination provides an important error-free mechanism for repairing DNA DSBs in mammalian cells and has a major role during DNA replication in the restart and repair of stalled or broken replication forks 5, 6 . In addition, homologous recombination is required for telomere maintenance; it provides a mechanism of telomere elongation that is an alternative to telomerase (ALT) 7, 8 and a pathway for telomere capping by facilitating t-loop formation 9 . The RAD51 recombinase has a central role in homologous recombination 10 , as it assembles nucleoprotein filaments at break sites to initiate the search for a homologous recombination target sequence. The assembly of RAD51 at DNA breaks depends on BRCA2. In mammalian cells, a family of proteins known as the RAD51 paralogs, consisting of five proteins (RAD51B, RAD51C, RAD51D, XRCC2 and XRCC3 (ref. 11)), also contribute to RAD51 filament assembly. In addition, some of the RAD51 paralogs act upstream of RAD51 and BRCA2 in DNA damage signaling through checkpoint kinases 12 .
Telomeres, the natural ends of linear chromosomes, consist of repetitive G-rich DNA and associated proteins. One of their prominent functions is to protect chromosome ends from degradation and fusion. Failure of telomere protection can have deleterious effects that result in chromosomal end-to-end fusions, breakage and rearrangements 13 . Thus, telomere integrity is essential for genome stability.
Telomere integrity in mammalian cells comprises two aspects: the maintenance of telomere length and the formation and stability of capping structures. The first aspect requires telomerase-a reverse transcriptase that uses an RNA component as a template for telomere elongation and acts after telomere replication is complete. The second aspect, formation of a protective telomere structure, is thought to involve the formation of a telomeric t-loop. This protective structure is assembled when the 3′ single-stranded overhang invades doublestranded telomeric DNA tracts to form a displacement loop at the invasion site. The formation of the t-loop is essential for preventing the recognition of chromosome ends as broken DNA and consequent checkpoint activation 13 .
Two mammalian recombination proteins, RAD51D and RAD54, act at telomeres 14, 15 . Deletion of these homologous recombination activities leads to telomere shortening and loss of capping even in a r t i c l e s the presence of telomerase, supporting the notion that homologous recombination contributes to telomere protection. Homologous recombination could promote telomere elongation by inter-or intratelomere recombination or could facilitate the formation of the protective t-loop structure 16 . Indeed, the recombination activities of RAD51, RAD52 and XRCC3 associate with telomeres during the S and G2 phases of the cell cycle, when capping is restored after DNA replication 9 . However, the mechanism by which recombination promotes telomere integrity, the contributing homologous recombination activities and the consequences of compromised telomeric recombination for tumorigenesis remain unclear.
We set out to investigate the contribution of BRCA2 to telomere integrity. Using ChIP assays, we found that BRCA2 associated with telomeres during the S and G2 phases of the cell cycle, as does RAD51, and that the association of RAD51 with telomeres was decreased in cells in which BRCA2 was depleted using small inhibitory RNA (siRNA). As well as helping to maintain genomic stability by promoting DNA repair, BRCA2 also facilitated telomere replication and therefore was crucial for telomere length maintenance and for chromosome end protection. This adds an unanticipated dimension to the cellular roles of this tumor suppressor. These phenotypes are recapitulated in cells that lack the homologous recombination activities of RAD51 and RAD51C, suggesting that BRCA2 acts in telomere protection by promoting homologous recombination. We found that dysfunctional telomeres accumulated in mouse and human tumors that lacked BRCA2. This finding suggests that genomic instability in BRCA2-deficient cells and tumors is due in part to telomere dysfunction.
RESULTS
BRCA2 and RAD51 associate with telomeres during S phase RAD51 associates with telomeres during the late S and G2 phases of the cell cycle 9 , when telomere capping structures are restored after replication. Thus, RAD51 might facilitate capping reactions mediated by homologous recombination. We therefore investigated whether BRCA2, the loader of RAD51 at DNA DSBs, can also be detected at telomeres during these stages of the cell cycle.
We measured the association of RAD51 with telomeric DNA during cell cycle progression using chromatin immunoprecipitation (ChIP; Fig. 1 ). We performed ChIP analyses using HeLa 1.2.11 cells synchronized at the G1-S transition with a double thymidine block and released in fresh medium. The DNA and associated proteins in extracts prepared at several time points after this release were cross-linked, fragmented by sonication and then immunoprecipitated using various antibodies. We used 32 P-labeled probes corresponding to G-rich telomeric DNA strands to detect telomeric DNA ( Fig. 1a) . We used the telomere-associated protein RAP1 as a positive control. RAP1 associated with telomeres throughout the cell cycle, whereas RAD51 associated with telomeres specifically during the S and G2 phases, as reported 9 . When we immunoprecipitated BRCA2 from synchronized HeLa extracts, it also associated with telomeres specifically during the S and G2 phases, much as RAD51 did. Quantification of the ChIP signal ( Fig. 1a) indicated that BRCA2 telomeric association peaks before RAD51 during cell cycle progression. These results are consistent with the idea that BRCA2 associates with telomeres during their replication in S phase to load the RAD51 recombinase onto the chromosome ends. Subsequent homologous recombination reactions could facilitate both telomere replication and the re-establishment of telomere protection.
To test the possibility that BRCA2 functions as RAD51 loader at telomeres, we performed ChIP analyses with extracts prepared from asynchronous HeLa1.2.11 cells in which BRCA2 was depleted using siRNA ( Fig. 1b) . The anti-BRCA2 and anti-RAD51 antibodies pulled down BRCA2 and RAD51 with associated telomeric DNA in HeLa cells treated with a green fluorescent protein (GFP) siRNA control. When BRCA2 expression was inhibited using siRNA ( Supplementary  Fig. 1 ), the binding of both BRCA2 and RAD51 to telomeric DNA was abrogated, as suggested by telomeric ChIP signals at or below the level of the pre-immune serum. When we used a nontelomeric probe such as ribosomal DNA in the ChIP analysis, only the input extract generated a positive signal. This showed that BRCA2 was required for the association of RAD51 with telomeres and suggested that one of the roles of BRCA2 at telomeres could be mediated by its function as a RAD51 loader.
Telomere attrition due to BRCA2 deficiency in MEFs
Genomic instability leading to gross chromosomal rearrangements is a hallmark of BRCA2-deficient cells and tumors 2,4 . Short telomeres are known to contribute to genome instability in human cancer 17, 18 , but the possible contribution of the BRCA2 tumor suppressor to telomere maintenance has not been analyzed. As our ChIP assays showed that the association of BRCA2 with telomeres was regulated by the cell cycle, we studied telomere integrity in mouse embryonic fibroblasts (MEFs) in which Brca2 was conditionally deleted. The Brca2 sko allele contains a puromycin resistance marker and loxP sites flanking exons 3 and 4 ( Fig. 2a) . When treated with Cre recombinase, exons 3 and 4 of the Brca2 gene are deleted and a functional puromycin resistance gene is expressed, which allows the selection of Brca2-deficient cells. As Brca2 is essential for cell survival, we immortalized these MEFs by stable expression of TBX2, a suppressor of the p16 and p19 pathways 19 , to generate Brca2 sko/− (TBX2 OE ) MEFs. Transient expression of Cre recombinase from a self-deleting (Hit&Run) 20 retrovirus resulted in the efficient deletion of exons 3 and 4 of the Brca2 gene, as monitored by PCR analysis (Fig. 2a) , and concomitant loss of the BRCA2 protein as early as 2 d after selection ( Fig. 2b) . BRCA2 protein remained undetectable by western blotting up to 10 d after treatment with Cre.
To study the impact of Brca2 deletion on telomere length, we performed quantitative fluorescence in situ hybridization (Q-FISH) analysis with a telomere-specific probe on metaphase chromosomes isolated from Brca2 sko/− (TBX2 OE ) MEFs. We observed significant a r t i c l e s (P < 0.0001) telomere shortening in cells treated with Cre when compared with control cells treated with vector (pBabe) only ( Fig. 2c-e ). This shortening became more pronounced with increased time in culture and as cells underwent additional cell divisions. Telomere attrition progressed from 14.8% of control telomere length at day 2 to 27.2% at day 6 and 30.7% at day 10 after selection. Statistical analysis showed that this reduction in telomere length was significant (P < 0.0001) for the three individual treatments shown in Figure 2c -e. To verify that the observed telomere shortening was not a consequence of the specific genetic background of these cells, we measured telomere length by Q-FISH in independently derived MEFs carrying one Brca2 null allele and one allele in which exon 11 was flanked by loxP sites (Brca2 ex11/− ) 21 . As these MEFs also fail to proliferate after Brca2 deletion, we stably infected them with a construct expressing the SV40 large T (LT) antigen to generate Brca2 ex11/− LT-immortalized MEFs in which the second copy if Brca2 is inactivated by treatment with Cre. Q-FISH analysis of these MEFs showed a 20.3% reduction in the mean telomere length at day 6 after puromycin addition ( Supplementary Fig. 2) , which was also statistically significant (P < 0.0001). This indicates that BRCA2 is required for the maintenance of telomere length.
Telomere length determines attrition induced by RAD51 loss
The role of BRCA2 at the telomere could be mediated by its function as a RAD51 loader, in which it initiates strand invasion and recombination reactions that are required for telomere capping and elongation. Therefore, we investigated whether RAD51 has a similar role in the maintenance of telomere length. Like BRCA2, RAD51 is essential for cell viability. We therefore depleted this protein using shRNA in Trp53 −/− MEFs, which survive the homologous recombination repair defects and the subsequent accumulation of DNA damage. Treatment of MEFs with RAD51 shRNA led to the loss of RAD51 (as detected by western blotting) when compared with cells treated with control shRNA (Fig. 3a) .
We then compared telomere length in the RAD51-depleted MEFs with that found in the Brca2-deleted MEFs. At day 6, telomere length was decreased by 22.3% in RAD51-depleted MEFs as compared with control MEFs ( Fig. 3b ; P < 0.0001). We found a similar decrease in MEFs depleted of RAD51C ( Supplementary Fig. 3a,b ). This suggests that general homologous recombination activities are required for the maintenance of telomere length and opens the possibility that BRCA2 acts at telomeres to recruit RAD51.
We investigated whether the rapid reduction in telomere length that resulted from the deletion of homologous recombination activities in MEFs depended on telomere length. We depleted RAD51 using shRNA and measured telomere length using Q-FISH in MEFs established from late-generation Terc −/− G4 embryos, which show a r t i c l e s a significant (P < 0.0001) decrease in telomere length owing to the absence of telomerase 22 . Depletion of RAD51 mediated by shRNA led to the loss of detectable expression of RAD51 by western blotting (Fig. 3a) . Telomere length was decreased by 17% relative to control cells infected with GFP shRNA 6 d after treatment (Fig. 3b) . Although this shortening remained statistically significant (P < 0.0001), telomere shortening due to deficient homologous recombination affected longer telomeres more strongly than shorter telomeres. The similarity in telomere length phenotype between Brca2-and Rad51-deficient MEFs suggested that the function of BRCA2 in telomere homeostasis was mediated by recruiting RAD51 to telomeres. Consistent with the idea that RAD51 associated with uncapped telomeres, about 40% of the wild-type MEFs carried more than three telomeric RAD51 foci ( Supplementary Fig. 4 ) when visualized by colocalization of RAD51 immunofluorescent foci with telomeric TRF2 signals. The telomeric RAD51 staining was significantly reduced in MEFs that lacked BRCA2 after Cre-mediated excision of Brca2, suggesting that BRCA2 promotes the association of RAD51 with telomeres in these cells as it does in HeLa cells.
BRCA2 and RAD51 deletions induce telomere fragility
The abrogation of telomerase activity in mice results in telomere shortening at a rate of about 4.8 kb of telomeric repeat sequence per generation 23 . Our finding that up to 16 kb of telomere length was lost within 6 d of depletion of BRCA2 or RAD51 in MEFs, corresponding to only around nine cell divisions, suggested that these homologous recombination activities were required in a more profound way to sustain telomere length. Both Brca2 −/− and RAD51-depleted MEFs showed multiple telomeric signals (MTSs) at individual ends (Fig. 4a) . This type of telomere aberration has been described in the context of TRF2 overexpression and TRF1 deficiency [24] [25] [26] and has been associated with fragile telomeres generated by conditional deletion of TRF1 (refs. 27,28) . MTSs are thought to result from replication fork stalling and breakage within the G-rich telomeric sequence. To address whether MTSs in BRCA2-deficient cells result from a high rate of telomere breakage, we treated wild-type and BRCA2-deficient MEFs with aphidicolin, a drug that inhibits replication and induces fragile site instability and breakage 29 . MTSs became detectable in wild-type cells treated with aphidicolin and further increased in cells lacking BRCA2 that were treated with aphidicolin ( Fig. 4b) . Furthermore, MTS incidence increased over time after deletion of Brca2 (Fig. 4b) .
HeLa cells in which BRCA2 was depleted by siRNA showed a similar response to aphidicolin (Supplementary Fig. 1) , as did MEFs in which RAD51 was depleted by shRNA ( Fig. 4c) . MTSs also increased in Terc −/− G4 MEFs after shRNA-mediated depletion of RAD51 (Fig. 4d) , indicating that telomere fragility induced by the homologous recombination defect is also a feature of short telomeres. Consistent with the less pronounced telomere shortening in late-generation Terc −/− MEFs, this increase was less pronounced than in wild-type MEFs. We found a similar increase in MTSs in wild-type and Terc −/− MEFs depleted of RAD51C (Supplementary Fig. 3c) . These findings suggest that loss of homologous recombination activities leads to increased telomere fragility, possibly because homologous recombination is required to restart frequently stalled replication forks at telomeres. Defective restarting of replication forks might in turn be the cause of telomere shortening.
It has been shown that TRF1 facilitates telomere replication 27, 28 , and cells that lacked TRF1 showed a similar increase in MTSs to that seen here in cells with a deficiency in homologous recombination. To address the relationship between these activities, we depleted BRCA2 and RAD51 using shRNA in TRF1-deleted MEFs (Fig. 5a and data not shown). Loss of BRCA2 or RAD51 and TRF1 had an additive effect on MTSs (Fig. 5b) . This suggests that TRF1 and homologous recombination promote telomere replication by mutually independent mechanisms. Depletion of homologous recombination activities in the absence of TRF1 induced rapid arrest of cell growth (Fig. 5c) . This occurred despite immortalization of these cells by the SV40 large T antigen, which is thought to suppress both p53-and pRb-dependent senescence pathways. Additional DNA damage response pathways might have been activated to cause growth arrest in cells lacking BRCA2 or RAD51 and TRF1. a r t i c l e s
Damage response at uncapped telomeres in BRCA2-deficient cells
To characterize the consequences of the observed telomere dysfunction in Brca2-deficient cells, we investigated whether loss of BRCA2 resulted in increased telomere damage. Foci of γH2AX are markers for DSBs but also associate with short or dysfunctional telomeres, including uncapped 30, 31 and damaged 28 telomeres. Transient expression of Cre recombinase in Brca2 sko/− (TBX2 OE ) MEFs led to significant (P < 0.001) accumulation of γH2AX signals at telomeres (telomere dysfunction-induced foci, TIFs) as well as at other sites along chromosomes (Fig. 6a) . This is illustrated by γH2AX signals overlapping telomeres identified by FISH with a telomere-specific probe (Fig. 6a, inset) . Quantification of TIFs (Fig. 6b) showed that most of the control-treated cells (95%) contained fewer than three TIFs per metaphase, whereas 47% of the metaphase chromosome spreads obtained from Cre-treated cells carried three or more TIFs. Telomere damage in Brca2-deficient cells could be mediated by a defect in RAD51 assembly. Consistent with this possibility, depletion of RAD51 in MEFs using shRNA caused similar levels of TIF accumulation as did Brca2 deletion (Fig. 6c) . This finding suggests that defective RAD51 loading in the absence of BRCA2 elicits a DNA damage response at telomeres, which could be due to replication fork collapse or failed capping. Further supporting this conclusion, replication fork progression through telomeric regions, measured using a BrdU incorporation assay 9 , was slower in BRCA2-deficient HeLa cells than in wild-type cells (Supplementary Fig. 5a ). The frequency of hydroxyurea-induced TIF formation was correspondingly increased upon inactivation of BRCA2 in human and mouse cells (Supplementary Fig. 5b,c) . The RAD51 recombinase associates with mammalian telomeres specifically during the S and G2 phases of the cell cycle 9 , when telomeres are thought to become capped again following their replication. The ensuing DNA damage response facilitates the assembly of telomeric capping structures mediated by homologous recombination activities. To analyze the consequence of telomere damage in the absence of homologous recombination activities, we studied chromosome morphology and telomeres in mitotically arrested cells. MEFs that lacked BRCA2, RAD51 or RAD51C showed a small but significant (P < 0.05) increase in the frequency of telomere fusions that had telomeric DNA at the fusion site (Supplementary Fig. 6a) . These fusion events are indicative of loss of telomere protection. Even more pronounced was the incidence of telomere loss, quantified as telomere-free ends. This finding is consistent with problems in the completion of telomere replication in the absence of homologous recombination activities. These cells also accumulated chromatid-and chromosome-type breaks and further complex aberrations (tri-radials, quadri-radials), which could be a consequence of chromosome fusion-breakage cycles induced by telomere loss or could be due to deficient repair of DNA breaks (Supplementary Fig. 6b ).
To study in vivo the effect of BRCA2 inactivation on telomere integrity and its possible relevance for tumorigenesis, we analyzed TIF incidence in mammary tumors from K14Cre-Trp53 F/F Brca2 F/F double mutant mice 21 . We performed a combination of antibody staining and telomeric FISH on paraffin-embedded sections of mouse mammary gland tumors. These tumors accumulate 53BP1 foci at high levels compared to K14Cre-Trp53 F/F control tumors (data not shown), which suggests that they contain persistent DNA damage. A significant percentage (P < 0.0001) of 53BP1 foci colocalized with telomeres identified by FISH (Fig. 6d) in the Brca2deleted tumors, but fewer did so in tumors with intact BRCA2. The 53BP1 foci in these tumor sections had a relatively broad appearance. Despite this, our method could reliably differentiate 53BP1 foci at telomeres from those elsewhere (Fig. 6e) . Quantification of the percentage of 53BP1 foci that overlapped with telomeric FISH signals relative to the total number of 53BP1 foci detected in individual tumor cells ( Fig. 6f) suggested that there was a significant (P < 0.0001) increase in the frequency of uncapped telomeres in BRCA2-deficient tumors but not in BRCA1-or p53-deficient tumors. Thus, telomere uncapping is associated with loss of BRCA2 function during tumorigenesis.
Telomere shortening in BRCA2-deficient human mammary tumors BRCA1 and BRCA2 have fundamentally distinct roles in the response to DNA damage: BRCA2 functions as a RAD51 loader at the sites of damage, whereas BRCA1 is required during the initial steps of DNA damage signal amplification 32 . We therefore investigated whether these two tumor suppressors also contribute differently to telomere integrity. Brca1 SCo/− MEFs contain loxP sites flanking exons 5 and 6 of Brca1, in addition to one null Brca1 allele. Treatment with Cre recombinase generated Brca1-null MEFs 32 . We measured telomere length using Q-FISH in Brca1-deleted and control MEFs, and found that the two cell populations had similar telomere lengths (Fig. 7a) . When BRCA2 function was abrogated using Cre treatment in Brca2 sko/− MEFs, telomere length was significantly shorter (P < 0.0001) in the deleted cells than in untreated control cells (Fig. 7a) . Attrition of telomeric sequences in BRCA2-defective MEFs was linked with telomere fragility and telomere replication defects. Unlike loss of BRCA2, loss of BRCA1 did not lead to an increase in MTS frequency (Fig. 7b) , suggesting that BRCA1 was not required for telomere replication and consistent with the unaffected telomere length in Brca1-deficient cells.
The observation that loss of BRCA2, but not of BRCA1, led to abrupt telomere shortening in MEFs suggested that the maintenance of telomere length could be relevant to the pathogenesis of breast a r t i c l e s cancer. Therefore, we measured telomere length using Q-FISH on paraffin-embedded breast tumor microarrays from a collection of human breast tumors at the stage of in situ ductal carcinoma, carrying either BRCA1 or BRCA2 mutations 33 . Q-FISH was performed from germline mutation carriers. The collection contained 12 BRCA1-null and 10 BRCA2-null human breast tumors, from which we analyzed by Q-FISH n = 6,891 and n = 6,028 cells, respectively. Telomeres were significantly shorter (P < 0.0001) in BRCA2-null tumors than in BRCA1-null tumors ( Fig. 7c and data not shown) , and more cells had short telomeres when BRCA2 function was abolished (Fig. 7d) . This was consistent with the differential effects on telomere length of the conditional Brca1 or Brca2 deletions in MEFs (Fig. 7a) . Thus, telomere shortening is associated specifically with loss of BRCA2 function during tumorigenesis, reflecting fundamentally different roles for the BRCA1 and BRCA2 tumor suppressors in genome integrity.
DISCUSSION
Cells that have targeted mutations in Brca2 show a DNA repair defect 34 and spontaneous chromosomal instability 35 , both of which stem from a failure in recombinational DNA repair. However, to our knowledge, the effect of BRCA2 deletion on telomere function has not been addressed before now. Here we show that BRCA2 also promotes genomic stability by mediating homologous recombination reactions that are required for telomere maintenance and that this telomere function of BRCA2 might have clinical relevance.
Telomere homeostasis requires BRCA2
Our results indicate that BRCA2, along with the recombination activities of RAD51 and RAD51 paralogs, also act as suppressors of telomere shortening. The mean telomere shortening in Brca2deficient MEFs was about 14.8% at day 2, 27.2% at day 6 and 30.7% at day 10 after Brca2 inactivation by deletion of exons 3 and 4. a r t i c l e s This level of shortening was similar to that of MEFs depleted of RAD51 and RAD51C using shRNA (22% and 32%, respectively, 6 d after depletion). Moreover, the loss of another member of the RAD51 paralog family, RAD51D, which associates with telomeres in mammalian cells 14 , or of RAD54 (ref. 15 ), which promotes Holliday junction branch migration 36 , led to a comparable reduction in telomere length (21% and 32%, respectively). These results suggest that homologous recombination activities have a key role in telomere homeostasis. This role is probably mediated by the ability of homologous recombination to promote efficient replication. Fork stalling and subsequent breakage have been suggested as a mechanism that could cause rapid loss of telomeric sequences 37, 38 . The rapid telomere shortening in cells with deficiencies in homologous recombination could reflect the loss of large tracts of telomeric DNA owing to replication fork stalling at the telomere, which is converted to DSBs. Consistent with this hypothesis, in telomerasenegative MEFs (G4 Terc −/− ) with significantly shorter telomeres than wild type (16 versus 54 kb; P < 0.0001), the loss of telomeric sequences after depletion of the homologous recombination activities of RAD51 and RAD51C was less marked (17% and 11%, respectively). However, even these shorter telomeres depended on BRCA2 for their maintenance. This suggested that the maintenance of human telomeres, which are of similar length to those in G4 Terc −/− MEFs, could also depend on homologous recombination reactions.
BRCA2-mediated reactions in telomere replication and protection
Mammalian telomeres, owing to their G-rich repetitive DNA sequence and protective t-loop structures, represent a natural obstacle for passing replication forks. Paradoxically, components of telomeric complexes, which bind directly to telomeric DNA, facilitate telomere replication instead of obstructing it. Fork stalling at telomeric tracts has been reported in Schizosaccharomyces pombe Taz1 mutants, which lack an essential telomere-binding factor 37 . More recently, the mammalian telomere-binding proteins TRF1 and TRF2, which are orthologs of Taz1, were shown to be required for efficient fork progression in mammalian cells 27, 28, 39 . Telomeric factors could facilitate the removal of secondary structures in the telomeric DNA or recruit enzymatic activities (for example, helicases, topoisomerases) that can perform this function. Alternatively, a direct interaction between telomeric proteins and replication factors could be required for efficient replication of chromosome ends.
During normal progression through S phase, stalled replication forks are processed by homologous recombination. In cell lines in which this repair pathway is compromised, single-and doublestranded DNA breaks arise spontaneously, which indicates that they originate during DNA replication, when stalled or broken replication forks fail to be restarted. We have shown that in Brca2deficient MEFs telomeres become fragile, as indicated by the high frequency of MTSs, which are associated with replicative failure 27, 28 . The presence of disintegrated telomeres with a beads-on-a-string appearance, which often form connecting bridges between sister chromatids, is one of the most prominent features of telomeres in Brca2-deficient cells. MEFs that lacked RAD51 and RAD51C also showed a telomere fragility phenotype. Therefore, we propose that homologous recombination reactions contribute to telomere integrity by facilitating telomere replication. Consistent with this proposal, Brca1-defective MEFs in which homologous recombination is not severely compromised 32 do not show telomere replication defects and have normal telomere lengths.
These results lead to the prediction that longer telomeres are more likely to become fragile, correlating with an increased chance of fork stalling during replication of longer G-rich regions. Consistent with this, the shorter telomeres of G4 Terc −/− MEFs, although still prone to breakage in the absence of homologous recombination, accumulate fewer MTSs than their wild-type counterparts. In addition, abrogation of homologous recombination and deletion of TRF1 have an additive effect on MTS frequency. This supports the concept that the two pathways facilitate telomere replication independently of each other. TRF1 could mediate interactions between the telomeric complex and the replication machinery that are important for fork progression, whereas homologous recombination could ensure the restart of replication forks that break down in the G-rich telomere sequences despite the presence of TRF1. The telomere uncapping and telomere fusion phenotype in cells deficient in homologous recombination cells suggests that homologous recombination factors are involved in chromosome-end processing and protection. The association of BRCA2 and RAD51 with telomeres during the S and G2 phases in human cells shown here by ChIP analyses, together with immunofluorescence detection of RAD51 at a subset of telomeres in wild-type MEFs, also support the idea that homologous recombination reactions are involved in telomere capping during each cell cycle. BRCA2 stimulates the formation of RAD51 helical nucleoprotein filament on single-stranded DNA substrates, which can invade homologous DNA duplexes to mediate the formation of protective t-loop structures 9, 16 . Our finding that the telomere uncapping in the RAD51-depleted MEFs (end-toend fusions, telomere-free ends) was quantitatively similar to that of Brca2-deficient cells supports the idea that BRCA2-mediated RAD51 loading is involved in t-loop formation and suggests that both factors make equal contributions to the capping reaction. By comparison, the telomere-uncapping phenotype in MEFs that lacked RAD51C was milder, which suggests that RAD51C has a late role in t-loop homologous recombination reactions and that its inhibition has less marked consequences than inhibition of RAD51. Therefore, we favor the hypothesis that the homologous recombination-mediated mechanism of telomere capping involves conventional homologous recombination reactions, which engage the activities that are characteristic of this pathway of DNA repair and lead to the assembly of protective structures at telomeres.
An important consequence of telomere uncapping and replicationinduced telomere breakage is the activation of a DNA damage response at telomeres, as indicated by TIF formation 27, 28, 30, 31 . Consistent with the uncapping and inefficient replication, we found that TIF levels increased in MEFs that lacked BRCA2 or RAD51, similar to cells deficient in TRF1, a regulator of replication at the telomere 27, 28 . This supports the notion that BRCA2 promotes telomere replication and protection and thereby acts as a suppressor of a DNA damage response induced by loss of telomere integrity.
Clinical implications of telomere dysfunction
The accumulation of chromosome end-to-end fusions and telomerefree ends, a signature of telomere dysfunction, in addition to structural aberrations arising from stalled or broken replication forks (chromatid and chromosome breaks and complex aberrations) might initiate or promote carcinogenesis. Telomeres exposed as a consequence of uncapping or breakage can become re-ligated with each other, or with other broken DNA, to form dicentric chromosomes and initiate breakage-fusion-breakage cycles 18 . The high incidence of TIFs in Brca2-deficient mouse tumors suggests that this pathway is likely to contribute to the radical genome instability that is characteristic of these tumors.
The telomeric function described here adds a new dimension to the role of BRCA2 as a genome 'caretaker' . Inactivation of BRCA2 could promote, through this route, the mutation or altered expression of 'gatekeeper' genes that control cell division and death, and could thereby promote the proliferation of cancer cells 40 . Moreover, telomerase is activated during breast cancer progression at the stage of in situ ductal carcinoma, before the invasive phenotype is acquired 41 . As homologous recombination reactions may contribute along with telomerase to telomere maintenance, combined therapies that target both pathways could have additive effects. Therefore, drugs that target telomerase function could be more efficient in tumors in which the homologous recombination pathway is compromised.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
